X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,177 | -21,965 | -88,696 | -58,489 | -38,314 |
| Depreciation Amortization | 265 | 133 | 10,257 | 367 | 235 |
| Accounts payable and accrued liabilities | -605 | -713 | 1,166 | -695 | -592 |
| Other Working Capital | 391 | -300 | -1,498 | -172 | -3,672 |
| Other Operating Activity | 4,423 | 2,616 | 7,866 | 7,137 | 4,702 |
| Operating Cash Flow | $-38,703 | $-20,229 | $-70,905 | $-51,852 | $-37,641 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -60 | -22 | -615 | -602 | -582 |
| Investing Cash Flow | $-60 | $-22 | $-615 | $-602 | $-582 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -439 | -114 | N/A | N/A | N/A |
| Debt Repayment | -795 | -795 | N/A | N/A | N/A |
| Common Stock Issued | 5,855 | 5,877 | 76,245 | 51,675 | 54,117 |
| Common Stock Repurchased | N/A | N/A | -2,000 | -2,000 | N/A |
| Other Financing Activity | -12 | -12 | 0 | 0 | 0 |
| Financing Cash Flow | $4,609 | $4,956 | $74,245 | $49,675 | $54,117 |
| Exchange Rate Effect | -271 | -69 | -319 | -203 | -103 |
| Beginning Cash Position | 83,108 | 83,108 | 80,702 | 80,702 | 80,702 |
| End Cash Position | 48,683 | 67,744 | 83,108 | 77,720 | 96,493 |
| Net Cash Flow | $-34,425 | $-15,364 | $2,406 | $-2,982 | $15,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,703 | -20,229 | -70,905 | -51,852 | -37,641 |
| Capital Expenditure | -60 | -22 | -615 | -602 | -582 |
| Free Cash Flow | -38,763 | -20,251 | -71,520 | -52,454 | -38,223 |